Clinical trials

Former U.S. Rep. Chris Collins arrives at federal court for sentencing Friday, Jan. 17, 2020, in New York. Collins pleaded guilty last fall to insider trading and lying to the FBI. (AP Photo/Seth Wenig)
January 17, 2020 - 10:29 pm
NEW YORK (AP) — The first member of Congress to endorse Donald Trump to be president was sentenced Friday to two years and two months in federal prison after admitting he helped his son and others dodge $800,000 in stock market losses when he learned that a drug trial by a small pharmaceutical...
Read More
Former U.S. Rep. Chris Collins arrives at federal court for sentencing Friday, Jan. 17, 2020, in New York. Collins pleaded guilty last fall to insider trading and lying to the FBI. (AP Photo/Seth Wenig)
January 17, 2020 - 6:13 pm
NEW YORK (AP) — A former congressman who was one of President Donald Trump’s first supporters was sentenced Friday to two years and two months in federal prison after admitting he helped his son and others dodge $800,000 in stock market losses when he learned that a drug trial by a small...
Read More
FILE - In this Wednesday, Aug. 8, 2018, file photo, Republican U.S. Rep. Christopher Collins, center, is surrounded by reporters as he leaves federal court, in New York. On Friday, Jan. 17, 2020, U.S. District Judge Vernon Broderick in Manhattan will sentence Collins for conspiring in an insider trading scheme. (AP Photo/Mary Altaffer, File)
January 17, 2020 - 5:53 pm
NEW YORK (AP) — A former congressman who was one of President Donald Trump’s first supporters was sentenced Friday to two years and two months in federal prison after admitting he helped his son and others dodge $800,000 in stock market losses when he learned that a drug trial by a small...
Read More
In this Nov. 5, 2019 photo, in St. Francis, Wis., Amy Carter looks at her Yorkshire terrier-Chihuahua mix Bentley, who has epilepsy. Carter, gives him CBD, which she says has reduced his seizures. The federal government has yet to establish standards for CBD that will help pet owners know whether it works and how much to give. But the lack of regulation has not stopped some from buying it, fueling a $400 million CBD market for pets that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group. (AP Photo/Carrie Antlfinger)
January 07, 2020 - 11:16 am
Companies have unleashed hundreds of CBD pet health products accompanied by glowing customer testimonials claiming the cannabis derivative produced calmer, quieter and pain-free dogs and cats. But some of these products are all bark and no bite. “You'd be astounded by the analysis we've seen of...
Read More
In this Nov. 5, 2019 photo, in St. Francis, Wis., Amy Carter looks at her Yorkshire terrier-Chihuahua mix Bentley, who has epilepsy. Carter, gives him CBD, which she says has reduced his seizures. The federal government has yet to establish standards for CBD that will help pet owners know whether it works and how much to give. But the lack of regulation has not stopped some from buying it, fueling a $400 million CBD market for pets that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group. (AP Photo/Carrie Antlfinger)
January 07, 2020 - 9:43 am
Companies have unleash ed hundreds of CBD pet health products accompanied by glowing customer testimonials claiming the cannabis derivative produced calmer, quieter and pain-free dogs and cats. But some of these products are all bark and no bite. “You'd be astounded by the analysis we've seen of...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
November 28, 2018 - 6:03 pm
Australian Army veteran Wolfgang Neszpor was stunned when he heard his recently repaired shoulder squeak. "You could really hear it," he said. He recalled when the surgeon examined him and lifted up his arm, "It was a stupid amount of pain." Two months earlier, Neszpor, 36, had gotten a new...
Read More
November 26, 2018 - 7:23 am
DAKAR, Senegal (AP) — Congo has begun the first-ever trial to test the effectiveness and safety of four experimental Ebola drugs, the first time scientists have directly compared such treatments, the World Health Organization said Monday. The U.N. health agency described the multi-drug trial as "a...
Read More
November 26, 2018 - 5:49 am
LONDON (AP) — The World Health Organization says Congo has begun the first-ever trial to test the effectiveness and safety of four experimental Ebola drugs, the first time scientists have directly compared such treatments. In a statement Monday, the U.N. health agency described it as "a giant step...
Read More
Dr. Fatta Nahab, a neurologist who directs the Functional Imaging of Neurodegenerative Disorders Lab at the University of California San Diego Health's Movement Disorder Center, sits at his desk Monday, Sept 17, 2018, in San Diego. Nahab spent years going through regulatory hoops to get approval to import marijuana from Canada, to study whether cannabis can help treat essential tremor, a shaking condition affecting millions of people. (AP Photo/Julie Watson)
September 18, 2018 - 1:35 pm
SAN DIEGO (AP) — In a rare move, the U.S. government has approved the importation of marijuana extracts from Canada for a clinical trial, highlighting a new avenue for American researchers who have long had trouble obtaining the drug for medical studies. The University of California San Diego's...
Read More

Pages